ArticleMethodsX2023
LogNNet model as a fast, simple and economical AI instrument in the diagnosis and prognosis of COVID-19.
Article in MethodsX, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 9 citations in OpenAlex.
- Risk factors for severe COVID-19 and development of a predictive model.BMC pulmonary medicine · 2025Article
- Identification of right ventricular dysfunction with LogNNet based diagnostic model: A comparative study with supervised ML algorithms.Scientific reports · 2025Article
- The mean corpuscular volume (MCV) is a hematological biomarker associated with COVID-19 mortality risk.Biomarkers in medicine · 2025Article
- A multicenter study on developing a prognostic model for severe fever with thrombocytopenia syndrome using machine learning.Frontiers in microbiology · 2025Article
- Single Cell Transcriptomics Genomics Based on Machine Learning Algorithm: Constructing and Validating Neutrophil Extracellular Trap Gene Model in COPD.International journal of general medicine · 2025Article
- Article
Corrections and comments
- Erratum issued
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rapid and effective detection of the diagnosis and prognosis of COVID-19 disease is important in terms of reducing the mortality of the disease and reducing the pressure on health systems. Methods such as PCR testing and computed tomography used for this purpose in current health systems are costly, require an expert team and take time. This study offers a fast, economical and reliable approach for the early diagnosis and prognosis of infectious diseases, especially COVID-19. For this purpose, characteristics of a large population of COVID-19 patients were determined (51 different routine blood values) and calibrated. In order to determine the diagnosis and prognosis of the disease, the calibrated features were run with the LogNNet model. LogNNet has a simple algorithm and performance indicators comparable to the most efficient algorithms available.This approach pointed out that routine blood values contain important information, especially in the detection of COVID-19, and showed that the LogNNet model can be used as an economical, safe and fast alternative tool in the diagnosis of this disease.-In the LogNNet feedforward neural network, a feature vector is passed through a specially designed reservoir matrix and transformed into a new feature vector of a different size, increasing the classification accuracy.-The presented network architecture can achieve 80%-99% classification accuracy using a range of weightings on devices with a total memory size of 1 to 29 kB constrained.-Due to the chaotic mapping procedures, the RAM usage in the LogNNet neural network processing process is greatly reduced. Hence, optimization of chaotic map parameters has an important function in LogNNet neural network application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.